0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Communications |

The Effect of Estrogen Replacement Therapy on Plasma Nitric Oxide and Endothelin-1 Levels in Postmenopausal Women

Patricia J.M. Best, MD; Peter B. Berger, MD; Virginia M. Miller, PhD; and Amir Lerman, MD
[+] Article and Author Information

From the Mayo Clinic and Mayo Foundation, Rochester, Minnesota. Grant Support: By grants HL07111-21D and HL51736 from the National Institutes of Health, the Miami Heart Research Institute, the Rappaport Program in Vascular Biology, and the Mayo Foundation. Requests for Reprints: Amir Lerman, MD, Department of Internal Medicine and Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Current Author Addresses: Drs. Best, Berger, and Lerman: Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1998;128(4):285-288. doi:10.7326/0003-4819-128-4-199802150-00006
Text Size: A A A

Background: Estrogen replacement therapy (ERT) in postmenopausal women decreases cardiac mortality and improves endothelial function. The endothelium regulates vascular tone and growth by releasing such factors as nitric oxide and endothelin-1.

Objective: To determine whether ERT alters the balance between the total oxidized products of nitric oxide and endothelin-1.

Design: Single-arm, before–after clinical trial.

Setting: Outpatient clinical research center of an academic medical center.

Patients: 15 postmenopausal women.

Intervention: Treatment with 17β-estradiol for 6 months and a 10-day course of methoxyprogesterone every 3 months.

Measurements: Plasma nitric oxide and endothelin-1 levels were measured at baseline and after 6 months of ERT.

Results: The mean baseline nitric oxide level was 27.5 nmol/mL (range, 20.3 to 34.8 nmol/mL) and increased by a mean of 7.2 nmol/mL (range, 0.2 to 14.1 nmol/mL) (P = 0.04). The mean baseline plasma endothelin-1 level was 16.4 pg/mL (range, 12.0 to 20.8 pg/mL) and decreased by a mean of 3.9 pg/mL (range, 0.4 to 7.8 pg/mL) (P = 0.04). The mean baseline ratio of nitric oxide to endothelin-1 was 2.0 (range, 1.3 to 2.8) and increased by 1.2 (range, 0.1 to 2.2) (P = 0.03).

Conclusion: ERT results in an increased ratio of nitric oxide to endothelin-1. This may be one mechanism by which ERT provides cardiovascular benefit.

Figures

Grahic Jump Location
Figure 1.
Individual patient data on plasma oxidized products of nitric oxide (left) and endothelin-1 (right) before and after 6 months of estrogen replacement therapy in 15 postmenopausal women.

The dashed lines represent mean changes.

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)